Filed: 2/14/2025ACC: 0000919574-25-001439
📋 What this filing means
CAXTON CORP filed this quarterly 13F‑HR report disclosing 15 equity positions with a total reported market value of $16.64M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
15
Positions
$16.64M
Total AUM (reported)
3.74M
Total Shares
Allocation by class
COM$7.43M44.7%
COM NEW$6.75M40.6%
TR UNIT$1.65M9.9%
CL B NEW$513.6K3.1%
GOLD SHS$283.1K1.7%
Portfolio Concentration
Top 3$14.95M89.8%
4–10$1.49M9.0%
11–25$198.0K1.2%
Top 3 weight
89.8%
Top 10 weight
98.8%
Voting Authority Distribution
Total shares with voting rights: 3.74M
Sole
Full voting authority
3.74M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole15
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings15
Rows:
XERIS BIOPHARMA HOLDINGS INC
SOLEShares2.02M
TypeSH
Market value$6.83M
41.06%
Sole
2.02M
Shared
0.00
None
0.00
REZOLUTE INC
SOLEShares1.32M
TypeSH
Market value$6.46M
38.85%
Sole
1.32M
Shared
0.00
None
0.00
SPDR S&P 500 ETF TR
SOLEShares2.82K
TypeSH
Market value$1.65M
9.94%
Sole
2.82K
Shared
0.00
None
0.00
BERKSHIRE HATHAWAY INC DEL
SOLEShares1.13K
TypeSH
Market value$513.6K
3.09%
Sole
1.13K
Shared
0.00
None
0.00
SPDR GOLD TR
SOLEShares1.17K
TypeSH
Market value$283.1K
1.70%
Sole
1.17K
Shared
0.00
None
0.00
MIND MEDICINE MINDMED INC
SOLEShares34.07K
TypeSH
Market value$237.1K
1.43%
Sole
34.07K
Shared
0.00
None
0.00
BICARA THERAPEUTICS INC
SOLEShares10.94K
TypeSH
Market value$190.6K
1.15%
Sole
10.94K
Shared
0.00
None
0.00
LEXEO THERAPEUTICS INC
SOLEShares17.85K
TypeSH
Market value$117.5K
0.71%
Sole
17.85K
Shared
0.00
None
0.00
KYVERNA THERAPEUTICS INC
SOLEShares22.98K
TypeSH
Market value$86.0K
0.52%
Sole
22.98K
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
SOLEShares43.47K
TypeSH
Market value$63.0K
0.38%
Sole
43.47K
Shared
0.00
None
0.00
CARDIFF ONCOLOGY INC
SOLEShares13.29K
TypeSH
Market value$57.7K
0.35%
Sole
13.29K
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares16.39K
TypeSH
Market value$53.3K
0.32%
Sole
16.39K
Shared
0.00
None
0.00
GLYCOMIMETICS INC
SOLEShares203.58K
TypeSH
Market value$50.9K
0.31%
Sole
203.58K
Shared
0.00
None
0.00
CONTEXT THERAPEUTICS INC
SOLEShares18.40K
TypeSH
Market value$19.3K
0.12%
Sole
18.40K
Shared
0.00
None
0.00
ADICET BIO INC
SOLEShares17.49K
TypeSH
Market value$16.8K
0.10%
Sole
17.49K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
XERIS BIOPHARMA HOLDINGS INCSOLE | COM | 2.02M | SH | $6.83M 41.06% | 2.02M | 0.00 | 0.00 |
REZOLUTE INCSOLE | COM NEW | 1.32M | SH | $6.46M 38.85% | 1.32M | 0.00 | 0.00 |
SPDR S&P 500 ETF TRSOLE | TR UNIT | 2.82K | SH | $1.65M 9.94% | 2.82K | 0.00 | 0.00 |
BERKSHIRE HATHAWAY INC DELSOLE | CL B NEW | 1.13K | SH | $513.6K 3.09% | 1.13K | 0.00 | 0.00 |
SPDR GOLD TRSOLE | GOLD SHS | 1.17K | SH | $283.1K 1.70% | 1.17K | 0.00 | 0.00 |
MIND MEDICINE MINDMED INCSOLE | COM NEW | 34.07K | SH | $237.1K 1.43% | 34.07K | 0.00 | 0.00 |
BICARA THERAPEUTICS INCSOLE | COM | 10.94K | SH | $190.6K 1.15% | 10.94K | 0.00 | 0.00 |
LEXEO THERAPEUTICS INCSOLE | COM | 17.85K | SH | $117.5K 0.71% | 17.85K | 0.00 | 0.00 |
KYVERNA THERAPEUTICS INCSOLE | COM | 22.98K | SH | $86.0K 0.52% | 22.98K | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCSOLE | COM | 43.47K | SH | $63.0K 0.38% | 43.47K | 0.00 | 0.00 |
CARDIFF ONCOLOGY INCSOLE | COM | 13.29K | SH | $57.7K 0.35% | 13.29K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 16.39K | SH | $53.3K 0.32% | 16.39K | 0.00 | 0.00 |
GLYCOMIMETICS INCSOLE | COM | 203.58K | SH | $50.9K 0.31% | 203.58K | 0.00 | 0.00 |
CONTEXT THERAPEUTICS INCSOLE | COM | 18.40K | SH | $19.3K 0.12% | 18.40K | 0.00 | 0.00 |
ADICET BIO INCSOLE | COM | 17.49K | SH | $16.8K 0.10% | 17.49K | 0.00 | 0.00 |